Alerts
PDF
Other content recommended for you
- Current management of diabetes mellitus and future directions in care
- Protocol for a randomised controlled trial of the effect of dapagliflozin, metformin and exercise on glycaemic variability, body composition and cardiovascular risk in prediabetes (the PRE-D Trial)
- Advances in the management of diabetes: new devices for type 1 diabetes
- Novel therapies for diabetes mellitus in pregnancy
- Recommendations for management of diabetes during Ramadan: update 2020, applying the principles of the ADA/EASD consensus
- Diabetic ketoacidosis with SGLT2 inhibitors
- HbA1c variability in adults with type 1 diabetes on continuous subcutaneous insulin infusion (CSII) therapy compared to multiple daily injection (MDI) treatment
- Real-world risk of hypoglycemia-related hospitalization in Japanese patients with type 2 diabetes using SGLT2 inhibitors: a nationwide cohort study
- Sodium glucose co-transporter 2 inhibitors and cardiovascular event protections: how applicable are clinical trials and observational studies to real-world patients?
- Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study